期刊文献+

宫颈癌巨噬细胞浸润和VEGFR-3表达与淋巴结转移的关系 被引量:7

The Relationship between Macrophages Infiltration and VEGFR-3 Positive Vessel Density in Uterine Cervical Cancers
下载PDF
导出
摘要 目的:探讨宫颈癌组织巨噬细胞浸润与VEGFR-3阳性脉管密度的相关性及其与淋巴结转移的关系。方法:采用免疫组化SP法检测59例宫颈癌石蜡标本中CD68及VEGFR-3的蛋白表达,并应用计算机辅助图像分析系统对脉管的密度行定量分析。结果:淋巴结转移组巨噬细胞数和VEGFR-3阳性脉管密度明显高于无淋巴结转移组(P<0.05、P<0.01)。随临床分期或病理分级增高,巨噬细胞数和VEGFR-3阳性脉管密度均有增加的趋势,但无统计学差异(P>0.05)。巨噬细胞数和VEGFR-3阳性脉管密度成正相关(r=0.318,P=0.014)。结论:宫颈癌中浸润的巨噬细胞通过促进淋巴管生成与宫颈癌的淋巴结转移密切相关。 Objective: To investigate the correlation between macrophages and VEGFR-3 positive vessel density in uterine cervical cancers and their relationship with lymphatic metastasis. Methods: The CD68 and VEGFR-3 were identified by immunohistochemically in the 59 parafin specimens respectively. The density of VEGFR-3 positive vessel was assessed quantitatively by Computer-assisted video analysis system. Results: The mean macrophage counts and VEGFR-3 positive vessel density were significantly higher in the lymph node metastasis group than in the non-metastasis group (P<0.05,P<0.01). The mean macrophage counts and VEGFR-3 positive vessel density did not correlated with tumor stage and clinical stage. A positive correlation was found between the mean macrophage counts and VEGFR-3 positive vessel density in tumors (P=0.014). Conclusions: Macrophages infiltration triggers lymphatic angiogenesis in cervical cancers, which may be closely related to lymph node metastasis.
作者 刘冬菊 娄阁
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2005年第4期189-191,共3页 Chinese Journal of Clinical Oncology
基金 黑龙江省留学回国基金资助(编号:1co2c17)
关键词 宫颈肿瘤 淋巴结转移 巨噬细胞 VEGFR-3 Cervix neoplasms Lymphatic metastasis Macrophage Vascular Endothelial Growth Factor Receptor-3
  • 相关文献

参考文献10

  • 1于大海,温玉明,孙劲东,韦山良,谢鸿鹏,庞芳河.口腔癌VEGF-C mRNA表达和血管及淋巴管生成与淋巴道转移关系的研究[J].癌症,2002,21(3):319-322. 被引量:20
  • 2刘芳.血管内皮生长因子受体3[J].广州医学院学报,2002,30(2):73-75. 被引量:5
  • 3白晓燕,夏养志.胃癌巨噬细胞浸润和微血管密度与侵袭转移的关系[J].中国体视学与图像分析,2003,8(4):207-210. 被引量:7
  • 4胡承杰,于振坤,韩德民.肿瘤相关淋巴管分布与肿瘤淋巴道转移[J].国外医学(耳鼻咽喉科学分册),2003,27(1):17-19. 被引量:2
  • 5Kitadai Y, Amioka T. Haruma K. et al. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas[]]. Int J Cancer, 2001, 93(5):662 - 666.
  • 6van Trappen PO, Pepper MS. Lymphatic dissemination of tumour cell and the formation of micrometastases [I]. Lancet,Oncol,2002.3(1): 44-52.
  • 7Schoppmann SF, Birner P, Studer P, et al. Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer[]]. Anticancer Res, 2001,21 (4A): 2351 - 2355.
  • 8Ono M. Torisu H, Fukushi J, et al. Biological implications of macrophage infiltration in human tumor angiogenesis [l]. Cancer Chemother Pharmacol, 1999, 43:69-71.
  • 9Schutyser E, Struyf S, Proost P. et al. Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma[J].J Biol Chem, 2002, 277(27): 24584-24593.
  • 10Schoppmann SF, Birner P, Stockl J, et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis[J]. Am J Pathol, 2002,161(3): 947-956.

二级参考文献39

  • 1Cao Y, Linden P, Farnebo J, Cao R, et al. Vascular endothelial growth factor C induces angiogenesis in vivo [J]. Proc Natl Acad Sci U S A, 1998, 95(24):14389-14394.
  • 2Hofmann M, Rudy W, Zoller M, et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumour cell line [J]. Cancer Res, 1991, 51:5292-5297.
  • 3Tsurusaki T, Kanda S, Sakai H, et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis [J]. Br J Cancer, 1999, 80(1-2):309-313.
  • 4Lymboussaki A, Olofsson B, Eriksson U, et al. Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia [J]. Circ Res, 1999,85(11):992-999.
  • 5Roselle J, Eisma BS, Jeffrey D, et al. Vascular endothelial growth factor expression in head and neck squamous cell carcinoma [J]. Am J Surg, 1997, 174: 513-517.
  • 6Dray TG, Hardin NJ, Sofferman RA, et al. Angiogenesis as a prognostic marker in early head and neck cancer [J]. Ann Otol Rhiol Laryngol, 1995; 104:724-729.
  • 7Ari Ristim, Kirsi Narko, Berndt Enholm, et al. Proinflammatory Cytokines Regulate Expression of the Lymphatic Endothelial Mitogen Vascular Endothelial Growth Factor-C [J]. J Biol Chem, 1998, 273:8413-8418.
  • 8Berger DP, Herbstritt L, Dengler WA, et al. Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies [J]. Ann Oncol, 1995, 6: 817-825.
  • 9Joukov V, Kumar V, Sorsa T, et al. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities [J]. J Bio Chem, 1998, 273(12):6599-6602.
  • 10Oh SJ, Jeltsch MM, Birkenhager R, et al. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane [J]. Dev Biol, 1997,188(1):96-109.

共引文献30

同被引文献51

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部